Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a […]
Sanofi-GSK Next-generation COVID-19 Booster Delivers Strong Immune Response Against Variants of Concern, Including Omicron
Sanofi today reports data from two trials, VAT02 Cohort 2 and COVIBOOST VAT013, conducted with […]
Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over
Novavax, Inc. (NASDAQ: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious […]
Endo Tools Therapeutics Receives Positive Opinion From French High Authority for Health on Forfait Innovation Scheme to Treat Patients With Diabetes
Endo Tools Therapeutics (ETT), a company developing advanced endoscopic medical devices, today announces that HAS, […]
MEDICALGORITHMICS Secured FDA Approval for Qpatch Wearable
Qpatch is a state-of-the-art wearable device for measuring individual ECG signal to obtain accurate cardiac […]
LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System
LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that it has […]
Vironix Health has Partnered with The Landon Pediatric Foundation to Bring AI-Healthcare Technology to Southern California
Digital Health Company Vironix Health has teamed up with LPF to increase access to affordable healthcare and […]
RAD Adds Brain Tumor Technology to Portfolio
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a world-class developer of cutting-edge radiopharmaceutical products for […]
Pfizer Completes Acquisition of ReViral
Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of ReViral, a privately […]
H1 Secures an Extension on Its Series C to Further Its Mission of Creating a Healthier Future Through the Use of Connected and Accessible Healthcare Data
H1, the connecting force for global healthcare professional, clinical, science, and research information, announced today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more